From the Department of Anaesthesiology, General Intensive Care Medicine and Pain Management, Medical University of Vienna, Vienna, Austria; Department of Respiratory and Critical Care Medicine, Otto Wagner Hospital Vienna, Sozialmedizinisches Zentrum Baumgartner Höhe, Vienna, Austria; Department of Nephrology, Medical University of Vienna, Vienna, Austria; Department of Respiratory and Critical Care Medicine, Otto Wagner Hospital Vienna, Austria; Ludwig-Boltzmann Institute for COPD and Respiratory Epidemiology, Vienna, Austria; and Department of Nephrology, Landeskrankenhaus Steyr, Steyr, Austria.
Anesth Analg. 2015 Jan;120(1):123-129. doi: 10.1213/ANE.0000000000000419.
Recent studies have shown a decline in glomerular filtration rate and increased renal vasoconstriction after administration of normal saline when compared with IV solutions with less chloride. In this study, we investigated the impact of normal saline versus a chloride-reduced, acetate-buffered crystalloid on the incidence of hyperkalemia during cadaveric renal transplantation. The incidence of metabolic acidosis and kidney function were secondary aims.
In this prospective randomized controlled trial, 150 patients received normal saline or an acetate-buffered balanced crystalloid during and after cadaveric renal transplantation. Venous blood gases were obtained at the start of anesthesia and every 30 minutes until discharge from the postoperative surveillance unit. Serum creatinine and 24-hour urine output were obtained on postoperative days 1, 3, and 7.
Patients received a similar amount of fluid (median: 2625mL [interquartile range: 2000 to 3100] vs 2500 mL [2000 to 3050], P = 0.83). Hyperkalemia, defined as serum potassium >5.9 mmol/L, occurred in 13 patients (17%) in the saline and 15 (21%) in the balanced group (P = 0.56; difference between proportions -0.037 [-16.5% to 8.9%]). Minimum base excess was lower in the saline group compared with the balanced regimen (-4.5 mmol/L [-6 to -2.4] vs -2.6 mmol/L [-4 to -1], P < 0.001) and maximum chloride was significantly higher in the saline group (109 mmol/L [107 to 111] vs 107 mmol/L [105 to 109], P < 0.001). No difference in creatinine or urine output was seen postoperatively. Significantly more patients needed catecholamines in the saline group (30% vs 15%, P = 0.03).
The incidence of hyperkalemia differed by less than 17% between groups. Use of balanced crystalloid resulted in less hyperchloremia and metabolic acidosis. Significantly more patients in the saline group required administration of catecholamines for circulatory support.
与含氯量较低的 IV 溶液相比,最近的研究表明,在给予生理盐水后,肾小球滤过率下降,肾脏血管收缩增加。在这项研究中,我们研究了生理盐水与含氯量降低、醋酸盐缓冲的晶体液对尸体肾移植过程中高钾血症发生率的影响。代谢性酸中毒和肾功能是次要目标。
在这项前瞻性随机对照试验中,150 名患者在尸体肾移植期间和之后接受生理盐水或醋酸盐缓冲的平衡晶体液。在麻醉开始时和直到从术后监测单元出院前每 30 分钟采集静脉血气。在术后第 1、3 和 7 天采集血清肌酐和 24 小时尿量。
患者接受的液体量相似(中位数:2625mL[四分位距:2000 至 3100]与 2500 mL[2000 至 3050],P=0.83)。高钾血症定义为血清钾>5.9mmol/L,生理盐水组发生 13 例(17%),平衡组发生 15 例(21%)(P=0.56;比例差异-0.037[-16.5%至 8.9%])。与平衡方案相比,生理盐水组的最小基础不足更低(-4.5mmol/L[-6 至-2.4]与-2.6mmol/L[-4 至-1],P<0.001),生理盐水组的最大氯明显更高(109mmol/L[107 至 111]与 107mmol/L[105 至 109],P<0.001)。术后肌酐或尿量无差异。生理盐水组需要儿茶酚胺的患者明显更多(30%与 15%,P=0.03)。
两组之间的高钾血症发生率差异小于 17%。使用平衡晶体液可导致低氯血症和代谢性酸中毒。生理盐水组明显更多的患者需要儿茶酚胺进行循环支持。